Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
93,96,97 In addition, although emerging markers such as serum immunoreactive trypsin and chymotrypsin show theoretical potential, their clinical utility remains to be validated through further studies
Prescriptions are automatically free for everyone in Scotland, Wales and Northern Ireland, and for those in England aged over 60 or receiving certain benefits
Krantz, S
Description Reviewed by Dr
Neurobehavioral Toxicity Induced by Carbendazim in Rats and the Role of iNOS, Cox-2, and NF-kappaB Signalling Pathway